Last reviewed · How we verify
Sm29 Protein, Schistosoma Mansoni
Sm29 Protein, Schistosoma Mansoni is a Small molecule drug developed by Hospital Universitário Professor Edgard Santos. It is currently in Phase 1 development. Also known as: Pentavalent antimony (Sbv).
At a glance
| Generic name | Sm29 Protein, Schistosoma Mansoni |
|---|---|
| Also known as | Pentavalent antimony (Sbv) |
| Sponsor | Hospital Universitário Professor Edgard Santos |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Topical Sm29 in Combination With Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis. (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sm29 Protein, Schistosoma Mansoni CI brief — competitive landscape report
- Sm29 Protein, Schistosoma Mansoni updates RSS · CI watch RSS
- Hospital Universitário Professor Edgard Santos portfolio CI
Frequently asked questions about Sm29 Protein, Schistosoma Mansoni
What is Sm29 Protein, Schistosoma Mansoni?
Sm29 Protein, Schistosoma Mansoni is a Small molecule drug developed by Hospital Universitário Professor Edgard Santos.
Who makes Sm29 Protein, Schistosoma Mansoni?
Sm29 Protein, Schistosoma Mansoni is developed by Hospital Universitário Professor Edgard Santos (see full Hospital Universitário Professor Edgard Santos pipeline at /company/hospital-universit-rio-professor-edgard-santos).
Is Sm29 Protein, Schistosoma Mansoni also known as anything else?
Sm29 Protein, Schistosoma Mansoni is also known as Pentavalent antimony (Sbv).
What development phase is Sm29 Protein, Schistosoma Mansoni in?
Sm29 Protein, Schistosoma Mansoni is in Phase 1.
Related
- Manufacturer: Hospital Universitário Professor Edgard Santos — full pipeline
- Also known as: Pentavalent antimony (Sbv)